929
Views
36
CrossRef citations to date
0
Altmetric
Reviews

Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies

, MD PhD, , PharmD, , PharmD, , MD PhD, , PhD, , PharmD PhD, , MD PhD & , MD PhD show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Chun Wai Chan & Ying Nee Yap. (2018) Pharmacotherapeutic management of gout in patients with cardiac disease. Expert Opinion on Pharmacotherapy 19:18, pages 2011-2018.
Read now
Chris Walker & Luigi M. Biasucci. (2018) Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited. Postgraduate Medicine 130:1, pages 55-71.
Read now
Lena Boulakh & Gunnar H. Gislason. (2016) Treatment with non-steroidal anti-inflammatory drugs in patients after myocardial infarction – a systematic review. Expert Opinion on Pharmacotherapy 17:10, pages 1387-1394.
Read now
Pascal Richette, Augustin Latourte & Aline Frazier. (2015) Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend?. Expert Opinion on Drug Safety 14:8, pages 1259-1268.
Read now
János Tajti, Zsófia Majláth, Délia Szok, Anett Csáti & László Vécsei. (2015) Drug safety in acute migraine treatment. Expert Opinion on Drug Safety 14:6, pages 891-909.
Read now
Alfonso E. Bello, Jeffrey D. Kent, Amy Y. Grahn, Julie Ball & Robert J. Holt. (2015) One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia. Current Medical Research and Opinion 31:3, pages 397-405.
Read now
Alfonso E. Bello, Amy Y. Grahn, Julie Ball, Jeffrey D. Kent & Robert J. Holt. (2015) One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extension. Current Medical Research and Opinion 31:3, pages 407-420.
Read now
Giuseppe Gargiulo, Davide Capodanno, Giovanni Longo, Piera Capranzano & Corrado Tamburino. (2014) Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes. Expert Review of Cardiovascular Therapy 12:10, pages 1185-1203.
Read now
Eduardo Uchiyama, George N. Papaliodis, Ann-Marie Lobo & Lucia Sobrin. (2014) Side-Effects of Anti-Inflammatory Therapy in Uveitis. Seminars in Ophthalmology 29:5-6, pages 456-467.
Read now

Articles from other publishers (26)

Kayleigh J. Mason, Kelvin P. Jordan, Neil Heron, John J. Edwards, James Bailey, Felix A. Achana, Ying Chen, Martin Frisher, Alyson L. Huntley, Christian D. Mallen, Mamas A. Mamas, May Ee Png, Stephen Tatton, Simon White & Michelle Marshall. (2023) Musculoskeletal pain and its impact on prognosis following acute coronary syndrome or stroke: A linked electronic health record cohort study. Musculoskeletal Care 21:3, pages 749-762.
Crossref
Xian Fu, Hou-Hua Yin, Ming-Jun Wu, Xin He, Qing Jiang, Ling-Tong Zhang & Jun-Yan Liu. (2022) High Sensitivity and Wide Linearity LC-MS/MS Method for Oxylipin Quantification in Multiple Biological Samples. Journal of Lipid Research 63:12, pages 100302.
Crossref
Jonathan G. Yost, Caroline A. Browne & Irwin Lucki. (2022) (2R,6R)-hydroxynorketamine (HNK) reverses mechanical hypersensitivity in a model of localized inflammatory pain. Neuropharmacology, pages 109276.
Crossref
Minakshi A. Meshram, Utkarsha O. Bhise, Priyanka N. Makhal & Venkata Rao Kaki. (2021) Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR. European Journal of Medicinal Chemistry 225, pages 113804.
Crossref
Paras Karmacharya, Ravi Shahukhal, Cynthia S. Crowson, M. Hassan Murad, John M. DavisIIIIII, Pragya Shrestha, Delamo Bekele, Kerry Wright, Rikesh Chakradhar & Maureen Dubreuil. (2020) Effects of Therapies on Cardiovascular Events in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis. Rheumatology and Therapy 7:4, pages 993-1009.
Crossref
Samik Bindu, Somnath Mazumder & Uday Bandyopadhyay. (2020) Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochemical Pharmacology 180, pages 114147.
Crossref
Nicholas Moore. (2020) Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update. Drug Safety 43:4, pages 301-318.
Crossref
Nicholas Moore, Mai Duong, Sinem Ezgi Gulmez, Patrick Blin & Cecile Droz. (2019) Pharmacoepidemiology of non-steroidal anti-inflammatory drugs. Therapies 74:2, pages 271-277.
Crossref
Ian M. Ward & Amanda Knott. (2018) Practical Pearls About Current Rheumatic Medications. Primary Care: Clinics in Office Practice 45:2, pages 193-212.
Crossref
Yao-Chun Wen, Fei-Yuan Hsiao, Zhen-Fang Lin, Cheng-Chung Fang & Li-Jiuan Shen. (2018) Risk of stroke associated with use of nonsteroidal anti-inflammatory drugs during acute respiratory infection episode. Pharmacoepidemiology and Drug Safety 27:6, pages 645-651.
Crossref
Skaistė Kasciuškevičiūtė, Gintautas Gumbrevičius, Aušra Vendzelytė, Arūnas Ščiupokas, Kęstutis Petrikonis & Edmundas Kaduševičius. (2018) Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study. Medicina 54:2, pages 30.
Crossref
David Gelman, Arūnas Gelmanas, Dalia Urbanaitė, Ramūnas Tamošiūnas, Saulius Sadauskas, Diana Bilskienė, Albinas Naudžiūnas, Edmundas Širvinskas, Rimantas Benetis & Andrius Macas. (2018) Role of Multimodal Analgesia in the Evolving Enhanced Recovery after Surgery Pathways. Medicina 54:2, pages 20.
Crossref
Deepan Dalal, Maureen Dubreuil, Christine Peloquin, Tuhina Neogi, Yuqing Zhang, Hyon Choi & David Felson. (2017) Meloxicam and risk of myocardial infarction: a population-based nested case–control study. Rheumatology International 37:12, pages 2071-2078.
Crossref
Émilie Bouquet, Geoffrey Urbanski, Christian Lavigne & Pascale Lainé-Cessac. (2017) Unexpected drug-induced Raynaud phenomenon: Analysis from the French national pharmacovigilance database. Therapies 72:5, pages 547-554.
Crossref
Carina Monteiro, Cláudia Miranda, Filipa Brito, Cecília Fonseca & André R. T. S. Araujo. (2016) Consumption patterns of NSAIDs in central Portugal and the role of pharmacy professionals in promoting their rational use. Drugs & Therapy Perspectives 33:1, pages 32-40.
Crossref
Preethi Pirlamarla & Rachel M. Bond. (2016) FDA labeling of NSAIDs: Review of nonsteroidal anti-inflammatory drugs in cardiovascular disease. Trends in Cardiovascular Medicine 26:8, pages 675-680.
Crossref
Steven L. Kuklish, Stephen Antonysamy, Shobha N. Bhattachar, Srinivasan Chandrasekhar, Matthew J. Fisher, Adrian J. Fretland, Karen Gooding, Anita Harvey, Norman E. Hughes, John G. Luz, Peter R. Manninen, James E. McGee, Antonio Navarro, Bryan H. Norman, Katherine M. Partridge, Steven J. Quimby, Matthew A. Schiffler, Ashley V. Sloan, Alan M. Warshawsky, Jeremy S. York & Xiao-Peng Yu. (2016) Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters 26:19, pages 4824-4828.
Crossref
Christoforos TsantoulasElizabeth R. MooneyPeter A. McNaughton. (2016) HCN2 ion channels: basic science opens up possibilities for therapeutic intervention in neuropathic pain. Biochemical Journal 473:18, pages 2717-2736.
Crossref
Maria Mulka-Gierek, Bartosz Foroncewicz, Michał Florczak, Leszek Pączek, Marek Krawczyk & Krzysztof Mucha. (2016) The use of nonsteroidal anti-inflammatory drugs and analgesics by liver transplant recipients. Journal of Clinical Nursing 25:7-8, pages 1001-1005.
Crossref
Max Gordon, Agata Rysinska, Anne Garland, Ola Rolfson, Sara Aspberg, Thomas Eisler, Göran Garellick, André Stark, Nils P. Hailer & Olof Sköldenberg. (2016) Increased Long-Term Cardiovascular Risk After Total Hip Arthroplasty. Medicine 95:6, pages e2662.
Crossref
Carmelo Scarpignato & Corrado Blandizzi. 2016. NSAIDs and Aspirin. NSAIDs and Aspirin 61 89 .
Deepak Lokwani, Rajaram Azad, Aniket Sarkate, Pallu Reddanna & Devanand Shinde. (2015) Structure Based Library Design (SBLD) for new 1,4-dihydropyrimidine scaffold as simultaneous COX-1/COX-2 and 5-LOX inhibitors. Bioorganic & Medicinal Chemistry 23:15, pages 4533-4543.
Crossref
Jean-Paul Bounhoure, Gilles Bouvenot & Jean-Louis Montastruc. (2015) Risques cardiovasculaires des anti-inflammatoires non stéroïdiens (AINS) chez la personne âgée et pour des traitements longs. Bulletin de l'Académie Nationale de Médecine 199:6, pages 949-957.
Crossref
Kimberly R. Doherty, Dominique R. Talbert, Patricia B. Trusk, Diarmuid M. Moran, Scott A. Shell & Sarah Bacus. (2015) Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types. Toxicology and Applied Pharmacology 285:1, pages 51-60.
Crossref
Blerina Ahmetaj-ShalaNicholas S. KirkbyRebecca KnowlesMalak Al’YamaniSarah MaziZhen WangArthur T. TuckerLouise MackenziePaul C. J. ArmstrongRolf M. NüsingJames A. P. TomlinsonTimothy D. WarnerJames LeiperJane A. Mitchell. (2015) Evidence That Links Loss of Cyclooxygenase-2 With Increased Asymmetric Dimethylarginine. Circulation 131:7, pages 633-642.
Crossref
Waheed Asghar & Fakhreddin Jamali. (2014) The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review. Inflammopharmacology 23:1, pages 1-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.